| Dr Scott Daniel Walter, MD | |
|
191 Main St Ste 3, Manchester, CT 06042-3574 | |
| (860) 646-7704 | |
| (860) 647-7340 |
| Full Name | Dr Scott Daniel Walter |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 13 Years |
| Location | 191 Main St Ste 3, Manchester, Connecticut |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205127818 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0107X | Ophthalmology - Retina Specialist | 56701 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hartford Hospital | Hartford, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Retina Consultants Pc | 5799875951 | 8 |
News Archive
Understanding the way bacterial cells "talk" to each other could lead to more effective methods for fighting the often persistent and serious infections caused by the biofilms they form, says a Texas A&M University professor of chemical engineering who not only has deciphered their language but also discovered how to quell their conversation.
The anti-coagulant heparin reduces the likelihood of death from COVID-19 by 78% when administered in therapeutic doses to patients with signs of respiratory failure on admission to hospital, according to a study reported on October 14 in the British Medical Journal.
When the U.S. Preventive Services Task Force (USPSTF), an independent panel of experts in primary care and prevention, released its recommendations on mammography screenings for US women on November 16, 2009, there was immediate and considerable controversy.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that it will host a meeting for analysts and investors on October 15 in New York.
› Verified 5 days ago
| Entity Name | Retina Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093748071 PECOS PAC ID: 5799875951 Enrollment ID: O20071212000484 |
News Archive
Understanding the way bacterial cells "talk" to each other could lead to more effective methods for fighting the often persistent and serious infections caused by the biofilms they form, says a Texas A&M University professor of chemical engineering who not only has deciphered their language but also discovered how to quell their conversation.
The anti-coagulant heparin reduces the likelihood of death from COVID-19 by 78% when administered in therapeutic doses to patients with signs of respiratory failure on admission to hospital, according to a study reported on October 14 in the British Medical Journal.
When the U.S. Preventive Services Task Force (USPSTF), an independent panel of experts in primary care and prevention, released its recommendations on mammography screenings for US women on November 16, 2009, there was immediate and considerable controversy.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that it will host a meeting for analysts and investors on October 15 in New York.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott Daniel Walter, MD 191 Main St Ste 3, Manchester, CT 06042-3574 Ph: (860) 646-7704 | Dr Scott Daniel Walter, MD 191 Main St Ste 3, Manchester, CT 06042-3574 Ph: (860) 646-7704 |
News Archive
Understanding the way bacterial cells "talk" to each other could lead to more effective methods for fighting the often persistent and serious infections caused by the biofilms they form, says a Texas A&M University professor of chemical engineering who not only has deciphered their language but also discovered how to quell their conversation.
The anti-coagulant heparin reduces the likelihood of death from COVID-19 by 78% when administered in therapeutic doses to patients with signs of respiratory failure on admission to hospital, according to a study reported on October 14 in the British Medical Journal.
When the U.S. Preventive Services Task Force (USPSTF), an independent panel of experts in primary care and prevention, released its recommendations on mammography screenings for US women on November 16, 2009, there was immediate and considerable controversy.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that it will host a meeting for analysts and investors on October 15 in New York.
› Verified 5 days ago
Richard A. Fichman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 178 Hartford Rd, Manchester, CT 06040 Phone: 860-649-9973 | |
Andrew J Packer, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 191 Main St, Manchester, CT 06042 Phone: 860-646-7704 Fax: 860-647-7340 | |
Carol A. Stabile, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 732 Main St, Manchester, CT 06040 Phone: 860-649-5177 Fax: 860-643-4901 | |
Peter H. Judson, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 191 Main St, Manchester, CT 06042 Phone: 860-646-7704 Fax: 860-647-7340 | |
Daniel E. Petashnick, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 732 Main St, Manchester, CT 06040 Phone: 860-649-5177 Fax: 860-664-3490 | |
Marion J. Stoj, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 191 Main St, Manchester, CT 06042 Phone: 860-646-7704 Fax: 860-647-7340 |